[Question] ApoB — what am I missing here
Slightly embarrassed to be asking this, but: ApoB — what am I missing here.
Panicked about a single result, posted here, got told to repeat it, repeated it, and it was fine.
The confounding problem, stated plainly, because this board keeps stepping on it.
Substantial weight loss moves lipids, liver enzymes, insulin sensitivity markers and several others in its own right. If you are losing weight while taking something, any change in those markers has at least two candidate explanations and you cannot separate them from your own panel.
What you can do is standardise, take a baseline, keep the series long, and be honest in your posts about what is and is not attributable. The threads that say "this compound did X to my ALT" almost never have the design to support the claim, mine included.
ApoB counts atherogenic particles rather than the cholesterol they carry, which is why it can diverge from LDL-C and why it is the addition most worth making.
I will update this if the picture changes rather than quietly leaving it up.
best — the order this archive was captured in
Left up. It is a question about how to compare panels, not a request for interpretation.
Different laboratories use different assay platforms with different calibration. Comparing across labs adds a systematic offset that is invisible on the report.
That comparison crosses two labs with different assays. The difference you are describing may be the method.
Cosigning on baseline. The panel I regret most is the one I did not take before starting.
What did the repeat show?
assay method matters, especially between different labs
a single eGFR outside range is a reason to repeat, not to panic
Not convinced by the attribution. Weight loss alone moves that marker and you have no way to separate the two.
fasting state and time of day change more than people expect
baseline before you start is worth more than any later panel
Careful — that is a question for whoever ordered the panel, and nobody in this thread can answer it responsibly.
Added ApoB to the panel after a thread here. It told me something the standard lipid panel had been hiding.
hydration status moves a surprising number of markers
Did anything else change in that window — training, intake, hydration?
one measurement is a point, two is a line, three is a trend
Correcting my own comment: the two draws were 17 weeks apart, not the figure I gave earlier.
Draw at the same point in the week now, fasting, same lab. The noise dropped enormously once I standardised.
Small fix — a reference interval is not a treatment target, and the post above uses them interchangeably.
How many weeks between the two measurements?
one measurement is a point, two is a line, three is a trend
Adding the obvious one — take it to whoever ordered the panel. This board cannot read it for you.
Adding the obvious one — take it to whoever ordered the panel.
This is the sentence to read before anybody panics about a single value.
Compared two draws across two labs and spent a week worrying before finding out the assays were different.
- 1Left up. It is a question about how to compare panels, not a request for…10 comments in this branch · started by u/lipid_panel_larry
- 2one measurement is a point, two is a line, three is a trend8 comments in this branch · started by u/nnt_nate